MedPath

CEFAZOLIN

These highlights do not include all the information needed to use Cefazolin for Injection, USP safely and effectively. See full prescribing information for Cefazolin for Injection, USP.CEFAZOLIN FOR INJECTION, USPInitial U.S. Approval: 1973

Approved
Approval ID

cf13db9c-d8a1-489f-9aa0-fc70839d4bbc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 8, 2020

Manufacturers
FDA

Samson Medical Technologies, L.L.C.

DUNS: 102837429

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CEFAZOLIN SODIUM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66288-1100
Application NumberANDA065141
Product Classification
M
Marketing Category
C73584
G
Generic Name
CEFAZOLIN SODIUM
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 24, 2018
FDA Product Classification

INGREDIENTS (1)

Cefazolin SodiumActive
Quantity: 100 g in 1 1
Code: P380M0454Z
Classification: ACTIM

CEFAZOLIN SODIUM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66288-1300
Application NumberANDA065141
Product Classification
M
Marketing Category
C73584
G
Generic Name
CEFAZOLIN SODIUM
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 24, 2018
FDA Product Classification

INGREDIENTS (1)

Cefazolin SodiumActive
Quantity: 300 g in 1 1
Code: P380M0454Z
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFAZOLIN - FDA Drug Approval Details